Subcommittee E56.08 on Nano-Enabled Medical Products


    Showing results 1-2 of 2 matching ACTIVE standards under the jurisdiction of E56.08     E56 Home

    E3238-20 Standard Test Method for Quantitative Measurement of the Chemoattractant Capacity of a Nanoparticulate Material in vitro

    E3275-21 Standard Guide for Visualization and Identification of Nanomaterials in Biological and Nonbiological Matrices Using Darkfield Microscopy/Hyperspectral Imaging (DFM/HSI) Analysis

    Showing results 1-9 of 9 matching Proposed New Standards under the jurisdiction of E56.08     E56 Home

    WK63310 Visualization and Identification of Nanomaterials in Biological and Nonbiological Matrices Using Darkfield Microscopy with Hyperspectral Imaging Analysis

    WK67980 Quantifying Poly(ethylene glycol) Coating on the Surface of Gold Nanostructured Materials Using High Performance Liquid Chromatography with Evaporative Light Scattering Detection (HPLC/ELSD)

    WK67984 Cholesterol and Lipid Quantitation in Liposomal Drug Products using Ultra High-Performance Liquid Chromatography Separation with Triple Quadrupole Mass spectrometry Detection (UPLC-MS)

    WK67983 Cholesterol and Lipid Quantitation in Liposomal Drug Products using High Performance Liquid Chromatography Separation Evaporative Light Scattering Detection (HPLC-ELSD)

    WK60553 Evaluation of Nanoparticulate Material Internalization by Phagocytic Cells In Vitro

    WK60554 Detection of Nitric Oxide Production

    WK67982 Cholesterol and Lipid Quantitation in Liposomal Formulations using High Performance Liquid Chromatography Separation with Charged Aerosol Detector

    WK69051 Assessing the Activation of the Complement System in Human Plasma Through Quantification of iC3b Concentration by ELISA,

    WK75607 Characterization of Encapsulation, Extraction, and Analysis of mRNA in Lipid Nanoparticles for Drug Delivery

    0 matching WITHDRAWN standards under the jurisdiction of E56.08     E56 Home